methyl 2-[4-(4-chlorophenyl)-2,3,6-trimethyl-1-(1H-pyrazol-5-ylmethyl)pyrrolo[2,3-b]pyridin-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: methyl 2-[4-(4-chlorophenyl)-2,3,6-trimethyl-1-(1H-pyrazol-5-ylmethyl)pyrrolo[2,3-b]pyridin-5-yl]-2-[(2-methylpropan-2-yl)oxy]acetate
• 化学式: C₂₇H₃₁ClN₄O₃
• 分子量: 495.0
• InChiKey: YEXAKJDBMLRLNW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  35
• 可旋转键数：
  8
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.37
• 拓扑面积：
  82
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• NOVEL ANTIVIRAL PYRROLOPYRIDINE DERIVATIVES AND METHOD FOR PREPARING THE SAME
  申请人：KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY

  公开号：US20140249162A1

  公开（公告）日：2014-09-04

  The present invention relates to a pyrrolopyridine derivative represented by the Chemical Formula I, and a racemate or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and relates to an antiviral composition including the same as an active ingredient. The compound of the Chemical Formula I has excellent antiviral activity and selectivity for wild type and resistant HIV-1, and thereby is useful as a therapeutic agent for acquired immune deficiency syndrome (AIDS).

  本发明涉及一种由化学式I表示的吡咯吡啶衍生物，以及其外消旋体或立体异构体，或其药学上可接受的盐，并涉及包含其作为活性成分的抗病毒组合物。化学式I的化合物具有优异的抗病毒活性和对野生型和耐药HIV-1的选择性，因此可用作获得性免疫缺陷综合症（AIDS）的治疗剂。
• NOVEL ANTIVIRAL PYRROLOPYRIDINE DERIVATIVE AND A PRODUCTION METHOD FOR SAME
  申请人：Korea Research Institute of Chemical Technology

  公开号：EP2781519A1

  公开（公告）日：2014-09-24

  The present invention relates to a pyrrolopyridine derivative represented by the Chemical Formula I, and a racemate or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof, and relates to an antiviral composition including the same as an active ingredient. The compound of the Chemical Formula I has excellent antiviral activity and selectivity for wild type and resistant HIV-1, and thereby is useful as a therapeutic agent for acquired immune deficiency syndrome (AIDS).

  本发明涉及一种由化学式 I 代表的吡咯并吡啶衍生物及其外消旋物或立体异构体，或其药学上可接受的盐，并涉及一种包括其作为活性成分的抗病毒组合物。化学式 I 的化合物具有优异的抗病毒活性和对野生型和耐药 HIV-1 的选择性，因此可用作获得性免疫缺陷综合征（艾滋病）的治疗剂。